At the news
? NEUTRALIMPACT 3/10 8-K filed May 12, 2026 at 08:44 ET
Co-founder and Executive Vice Chairman Dr. Roy Schoenberg resigned from the board effective May 6, 2026, citing a new employment opportunity with no disagreement with the company. This follows the recent resignation of director Dr. Peter Slavin noted in the prior proxy filing, indicating ongoing board turnover at the $136M market cap telehealth company.
- Dr. Roy Schoenberg, co-founder and Executive Vice Chairman, resigned from the board effective May 6, 2026
- Resignation attributed to a new employment opportunity, not a disagreement with the company
- Follows the resignation of director Dr. Peter Slavin disclosed in the April 2026 proxy statement
- No replacement named; board composition now reduced
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access